Lantern Pharma Inc. (LTRN)
Nasdaq: LTRN · Pharmaceutical Preparations · Dallas, TX · filing with the SEC since 2019
Who owns Lantern Pharma Inc.
As filed with the SECHolders of 5% or more
1
Thomas A. Satterfield, Jr. holds 7.6% of Common Stock, $0.0001 par value per share, as its SCHEDULE 13G/A filed Jul 23, 2026 says.
Directors and officers
8
report now, of 10 people on the record since 2020. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Thomas A. Satterfield, Jr.
SCHEDULE 13G/A · filed Jul 23, 2026 · Common Stock, $0.0001 par value per share · 5.1% in Apr 3, 2026
Empery Asset Management, LP
SCHEDULE 13G/A · filed Oct 13, 2026 · Common Stock, $0.0001 par value per share · reported falling below 5%, from 9.99% in Aug 4, 2026
Bios Advisors Gp, LLC
SCHEDULE 13D/A · filed May 15, 2026 · Common Stock, par value $0.0001 per share · reported falling below 5%, from 7.4% in Apr 16, 2026
What LTRN reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
AF Chemicals
An entity · legal entity · owns, named in the 10-K filed Mar 30, 2026
Berkshire Sterile Manufacturing
An entity · legal entity · owns, named in the 10-K filed Mar 30, 2026
Curia Global, Inc.
An entity · legal entity · owns, named in the 10-K filed Mar 30, 2026
Fortrea Inc
An entity · legal entity · owns, named in the 10-K filed Mar 30, 2026
Fox Chase Cancer Center
An entity · legal entity · owns, named in the 10-K filed Mar 30, 2026
Harvest Integrated Research Organization
An entity · legal entity · owns, named in the 10-K filed Mar 30, 2026
Patheon API Services
An entity · legal entity · owns, named in the 10-K filed Mar 30, 2026
Piramal Pharma Solutions
An entity · legal entity · owns, named in the 10-K filed Mar 30, 2026
2 subsidiaries in 2 countries, from the list filed with the 10-K filed Mar 30, 2026.
Insider tradesForm 4
0sales
2purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$200,000bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window2 of 30 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Keyser D Jeffrey | director | 0 | $0 | 0 | 1 | $100,000 |
| Schalop Lee Troy | director | 0 | $0 | 0 | 1 | $100,000 |